This page sets out the regulatory framework under which Condor Research, operated by Atrio Sciences s.r.o. (Slovakia), supplies its catalogue. It is written to be clear rather than reassuring. The materials we sell are reference compounds for laboratory research, supplied strictly for research use only (RUO) and in vitro investigation. They are not medicines, not food supplements, not foods, not cosmetics, and they are not sold for human or veterinary consumption of any kind. This document is a statement of framework and responsibility — it is not legal advice, and it does not assert that any compound is lawful in any particular jurisdiction or for any particular use.
What does “Research Use Only” mean in the EU?
“Research Use Only” describes the intended purpose of a material: it is supplied to be used as a reagent in a laboratory setting — for analytical work, method development, and in vitro study — and for nothing else. The label is not a marketing flourish; it is the boundary that determines which body of EU law applies to the product and which does not. A material sold as RUO is offered outside the regulatory categories that govern products intended for human use. The moment a product is intended, presented, or used for diagnosis, prevention, treatment, or human consumption, a different and far stricter legal regime attaches to it. Condor’s catalogue is positioned firmly on the research side of that line, and we do not present, describe, or sell any item for a human or veterinary purpose.
We discuss the meaning and limits of this term in more depth in our guide ‘Research Use Only’: The Three Words Doing All the Work, and the binding terms appear in the Research Use Only Disclaimer.
Why are these compounds not medicines?
In the European Union, medicinal products for human use are governed principally by Directive 2001/83/EC, the Community code relating to medicinal products for human use.1 That directive defines a medicinal product by reference to two things: its presentation (a substance presented as having properties for treating or preventing disease) and its function (a substance used to restore, correct, or modify physiological functions, or to make a medical diagnosis). A medicinal product, so defined, requires a marketing authorisation before it may be placed on the market, and is subject to controls on manufacture, distribution, pharmacovigilance, and advertising.
Condor’s compounds fall outside that framework precisely because they are neither presented nor supplied for any of those purposes. We make no therapeutic claims, publish no human dosing, and describe no medical use. They are characterised analytically — for identity and purity — as research reagents, and that is the only basis on which they are offered. This is the substance of RUO, not a workaround: a reagent presented and used as a reagent is not a medicinal product, but the same molecule presented or used for human treatment would be, and would then require authorisation that we neither hold nor seek. We have written about how regulators approach this category in Research Peptides in 2026: How the FDA and EMA Treat Them.
Why are they not supplements or foods?
Food and food supplements in the EU are governed by food law, anchored in Regulation (EC) No 178/2002, which lays down the general principles and requirements of food law and establishes the European Food Safety Authority.2 Food law applies to substances intended to be, or reasonably expected to be, ingested by humans. Condor’s materials are not intended for ingestion and are not presented as food, food supplements, or nutritional products. They are laboratory reagents. Selling, labelling, or describing them as something a person could consume would place them under food law (or, depending on the claim, medicines law) and would be inconsistent with their RUO status. We do neither.
What legal framework actually applies to a research reagent?
Because these materials are chemical substances supplied for laboratory use rather than products for human use, the EU law most directly relevant to them concerns the safe handling, classification, and labelling of chemicals. Two regulations are central:
- REACH — Regulation (EC) No 1907/2006 on the Registration, Evaluation, Authorisation and Restriction of Chemicals.3 REACH is the EU framework for managing the risks of chemical substances, and it underpins the obligation to communicate hazard and safe-use information down the supply chain, including via the Safety Data Sheet (SDS).
- CLP — Regulation (EC) No 1272/2008 on the classification, labelling and packaging of substances and mixtures.4 CLP sets the rules for classifying chemical hazards and for the hazard labelling and pictograms that accompany a substance.
Both regulations are administered by the European Chemicals Agency (ECHA). In practice this means that, where applicable, a research reagent is accompanied by an SDS carrying CLP classification and labelling, so that the laboratory receiving it has the hazard and safe-handling information it needs. We describe how this works alongside our analytical testing on the Quality & Third-Party Testing page. We are deliberately careful here: we cite REACH and CLP as the relevant framework for chemical reagents, and we do not claim specific registration numbers, exemptions, or article-level interpretations that we have not confirmed. Whether and how a given obligation applies depends on the substance, the quantities, and the role of each party in the supply chain.
Where does the buyer’s responsibility begin?
RUO is a shared boundary, and the buyer holds one side of it. By purchasing, the buyer confirms that they are acquiring the material as a research reagent for laboratory or in-vitro use, that they have the competence and facilities to handle it safely in accordance with the accompanying SDS, and that they will not use it — or allow it to be used — for human consumption, veterinary use, clinical application, diagnosis, or any therapeutic purpose. The buyer is also responsible for knowing and complying with the laws that apply to them: the legal status of a specific compound, and the conditions under which it may be imported, possessed, or used, can vary by country and by intended use. Condor cannot and does not assess that on the buyer’s behalf.
We will not advise on the legality of a compound in any particular country, because doing so responsibly would require legal advice specific to a person, a place, and a purpose — which this is not. Our guide Is BPC-157 Legal? The Honest Answer Is “Legal for What?” illustrates why a flat “yes or no” to legality is usually the wrong question.
Our shipping and restriction policy
Condor ships within the EU from its warehouse in Slovakia. We do not ship a product to a destination where we understand that product, or that category of product, to be restricted or prohibited, and we reserve the right to decline or cancel any order on that basis. This is a conservative position taken to keep both the buyer and Condor on the right side of applicable rules; it is not a representation that any product is lawful in any destination we do ship to. Buyers remain responsible for the legality of their own purchase and use.
What this page does — and does not — claim
To be precise about the limits of this statement:
- It does state that Condor’s materials are supplied RUO, are not medicines, supplements, foods, or cosmetics, and are not sold for human or veterinary use.
- It does identify the EU frameworks that are relevant: medicines under Directive 2001/83/EC (from which RUO reagents are outside), food law under Regulation 178/2002, and chemical handling/classification under REACH and CLP.
- It does not provide legal advice, country-by-country guidance, or any assurance that a specific compound is lawful in a specific place or for a specific use.
- It does not claim certifications, registrations, or regulatory approvals that Condor does not hold.
If you need a definitive answer on the legal status of a compound for your jurisdiction and intended research, consult a qualified professional in that jurisdiction. For questions about this position, contact info@condorresearch.com.
Frequently asked questions
Are Condor Research products medicines?
No. They are reference compounds supplied for research use only and in-vitro investigation. They are not presented or sold for treating, preventing, or diagnosing any condition, and they therefore fall outside the EU medicinal-products framework set by Directive 2001/83/EC. They carry no human dosing and no therapeutic claims.
Are they food supplements?
No. They are laboratory reagents, not products intended for human ingestion, and are not presented as foods or supplements. Substances intended to be ingested by humans fall under EU food law (Regulation (EC) No 178/2002), which does not apply to materials supplied for research use only.
What EU law applies to research reagents?
As chemical substances supplied for laboratory use, they sit primarily within the EU chemicals framework — REACH (Regulation (EC) No 1907/2006) and CLP (Regulation (EC) No 1272/2008), administered by the European Chemicals Agency. Where applicable, a Safety Data Sheet with CLP classification accompanies the material so it can be handled safely in a lab.
Will Condor confirm whether a compound is legal in my country?
No. The legal status of a specific compound depends on the jurisdiction and the intended use, and assessing it responsibly requires advice specific to your situation. Buyers are responsible for knowing and complying with the laws that apply to them. We frame the question of legality in our guide on whether BPC-157 is legal.
Does Condor ship everywhere?
No. We ship within the EU and decline orders to destinations where we understand a product or product category to be restricted or prohibited. Shipping to a destination is not a representation that a product is lawful there; the buyer remains responsible for the legality of their purchase and use.
All products supplied by Condor Research (Atrio Sciences s.r.o.) are for research use only / in vitro use. They are not for human or veterinary use, are not drugs, foods, supplements, or cosmetics, and are not for diagnostic or therapeutic purposes. This page describes a regulatory framework and the responsibilities of buyer and seller; it is not legal advice and does not assert the legality of any compound in any jurisdiction.
Condor Research · Scientific desk
References
- Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. EUR-Lex, CELEX 32001L0083. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32001L0083
- Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety. EUR-Lex, CELEX 32002R0178. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32002R0178
- Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). EUR-Lex, CELEX 32006R1907. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32006R1907
- Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures (CLP). EUR-Lex, CELEX 32008R1272. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32008R1272